Haibo. Sha, et.al., Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice., Physiological genomics, 2007, 31

http://rdf.ncbi.nlm.nih.gov/pubmed/17652166

Haibo. Sha, et.al., Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice., Physiological genomics, 2007, 31

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Timo
  http://metadb.riken.jp/db/mgi_rdf/MGI:3766100

class

http://purl.org/net/cito/citesAsAuthority

• Timo
  http://metadb.riken.jp/db/mgi_rdf/MGI:3766100

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased lean body mass_Timo/Timo
  http://metadb.riken.jp/0003960EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• impaired glucose tolerance_Timo/Timo
  http://metadb.riken.jp/0005293EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased mesenteric fat pad weight_Timo/Timo<+>
  http://metadb.riken.jp/0009298EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• increased renal fat pad weight_Timo/Timo
  http://metadb.riken.jp/0009302EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased mesenteric fat pad weight_Timo/Timo
  http://metadb.riken.jp/0009298EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• premature death_Timo/Timo
  http://metadb.riken.jp/0002083EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased body length_Timo/Timo<+>
  http://metadb.riken.jp/0001257EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• abnormal glucose homeostasis_Timo/Timo
  http://metadb.riken.jp/0002078EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased uterine fat pad weight_Timo/Timo
  http://metadb.riken.jp/0009306EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• polyphagia_Timo/Timo
  http://metadb.riken.jp/0001433EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating LDL cholesterol level_Timo/Timo
  http://metadb.riken.jp/0000182EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• abnormal fat pad morphology_Timo/Timo
  http://metadb.riken.jp/0005334EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• obese_Timo/Timo<+>
  http://metadb.riken.jp/0001261EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• increased percent body fat/body weight_Timo/Timo<+>
  http://metadb.riken.jp/0005458EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• increased total body fat amount_Timo/Timo
  http://metadb.riken.jp/0010024EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating leptin level_Timo/Timo
  http://metadb.riken.jp/0005669EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased aggression towards mice_Timo/Timo
  http://metadb.riken.jp/0001353EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating cholesterol level_Timo/Timo
  http://metadb.riken.jp/0005178EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased total body fat amount_Timo/Timo<+>
  http://metadb.riken.jp/0010024EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• obese_Timo/Timo
  http://metadb.riken.jp/0001261EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating insulin level_Timo/Timo
  http://metadb.riken.jp/0002079EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased percent body fat/body weight_Timo/Timo
  http://metadb.riken.jp/0005458EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• hepatic steatosis_Timo/Timo
  http://metadb.riken.jp/0002628EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• insulin resistance_Timo/Timo
  http://metadb.riken.jp/0005331EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating glucose level_Timo/Timo
  http://metadb.riken.jp/0005559EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo
• increased circulating LDL cholesterol level_Timo/Timo<+>
  http://metadb.riken.jp/0000182EB6CgTimoorIC57BL6JCBACaJTimoTimoTimoTimo
• increased body length_Timo/Timo
  http://metadb.riken.jp/0001257EB6CgTimoorIC57BL6JCBACaJTimoTimoTimo